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Abstract:  Susceptibility to chemical toxins has not been adequately addressed in risk 
assessment methodologies. As a result, environmental policies may fail to meet their 
fundamental goal of protecting the public from harm. This study examines how 
characterization of risk may change when susceptibility is explicitly considered in policy 
development; in particular we examine the process used by the U.S. Environmental 
Protection Agency (EPA) to set a National Ambient Air Quality Standard (NAAQS) for 
lead.  To determine a NAAQS, EPA estimated air lead-related decreases in child 
neurocognitive function through a combination of multiple data elements including 
concentration-response (CR) functions. In this article, we present alternative scenarios for 
determining a lead NAAQS using CR functions developed in populations more susceptible 
to lead toxicity due to socioeconomic disadvantage. The use of CR functions developed in 
susceptible groups resulted in cognitive decrements greater than original EPA estimates. 
EPA’s analysis suggested that a standard level of 0.15 µg/m
3 would fulfill decision criteria, 
but by incorporating susceptibility we found that options for the standard could reasonably 
be extended to lower levels. The use of data developed in susceptible populations would 
result in the selection of a more protective NAAQS under the same decision framework 
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applied by EPA. Results are used to frame discussion regarding why cumulative risk 
assessment methodologies are needed to help inform policy development. 
Keywords:  cumulative risk assessment;  neurocognitive functioning;  lead; nonchemical 
stressors; air standards; policy analysis 
 
1. Introduction 
To protect human health environmental chemical policies require accurate characterizations of both 
the exposure and the exposed. Individuals will be vulnerable to harm if they suffer from large chemical 
burdens but also if they exhibit increased susceptibility to toxic effects. Susceptibility to chemical 
toxins has not been adequately addressed in current risk assessment methodologies [1–3]. As a result, 
environmental policies may be failing to meet their fundamental goal of protecting the public from 
undue harm. 
The U.S. Environmental Protection Agency (EPA) developed cumulative risk assessments (CRAs) 
as a means to address complexity in public health issues. Ideally CRAs would evaluate combined risks 
from aggregate exposures to multiple stressors–both chemical and nonchemical. Although susceptibility 
is an integral aspect of CRA [4], thus far the bulk of assessments have concentrated on risks from 
chemical mixtures [5]. In practice we often lack data regarding which populations are most susceptible 
and why they are more greatly affected. When data is sparse, the use of conservative assumptions is 
believed to result in policies that are protective of the most vulnerable groups. However, our limited 
knowledge about the extent and impact of susceptibility in the population undermines these assumptions. 
The National Research Council (NRC) recently called for improving CRAs so that results would be 
more relevant to the needs and concerns of decision  makers and affected communities  [6]. One 
consequence of neglecting differential susceptibility in policy development might be the continuation 
of environmental health disparities. Individuals facing greater social and economic hardships tend to 
shoulder a greater exposure burden [7]. Due to the higher prevalence of potential chemical effect 
modifiers such as high stress levels, nutritional deficiencies, or co-morbid conditions, disadvantaged 
groups may also exhibit greater susceptibility to chemical toxicity [8–10]. 
To examine how consideration of susceptibility may affect  policy decisions we examine the 
analytical process used by EPA to set a National Ambient Air Quality Standard (NAAQS) for lead  
(73 FR 66964) [11]. Lead is an ideal candidate for illustrating complexities surrounding incorporation 
of susceptibility into policy. The metal is differentially associated with socioeconomic status (SES), 
travels across multiple media and exposure pathways, accumulates within the body, does not exhibit a 
threshold, and induces dysfunction across numerous physiological systems [12]. The 2008 revised 
NAAQS was developed using an “air-related IQ loss framework” through which EPA evaluated risk 
assessment, experimental, and epidemiological data to quantify the relationship between air lead and 
neurocognitive deficits. Crucial to the overall assessment of risk is the choice of concentration-
response  (CR) function: an estimate relating  changes in lead level to changes in health outcome. 
Specifically, EPA reviewed the epidemiological literature for CR functions assessing the relationship 
between blood lead and intelligence quotient (IQ) in children. Int. J. Environ. Res. Public Health 2012, 9  1079 
 
 
The CR functions evaluated by EPA represent the main effects of blood lead on IQ while 
controlling for other risk factors. Implicit in these estimates is the assumption that the relationship 
between lead and IQ does not vary across the levels of another factor. As numerous studies indicate 
however, this assumption may not hold true. Socioeconomic position has been shown to influence the 
extent of neurocognitive decline in a number of prospective [13–16] and cross-sectional studies [17–19]. 
Children in lower socioeconomic groups tend to exhibit greater loss of function than their more 
advantaged counterparts. 
By defining the sensitive population of concern to be a highly exposed subset of children, one could 
argue that EPA did integrate susceptibility into their decision analysis. However to address concerns 
related to issues of environmental justice and equity, a focus on “policy-relevant” susceptibilities is 
required. By “policy-relevant” we refer to modifiable factors that can help explain persistent 
socioeconomic health disparities. 
In this article, we present alternative scenarios for developing a lead NAAQS using CR functions 
developed in populations more highly susceptible to lead toxicity. Our objective is to examine how 
characterization of risk may change when susceptibility is explicitly and quantitatively considered in 
policy development. We focus on SES as a susceptibility factor because of its relevance for public 
health policy and prior evidence supporting its role as an effect modifier of lead toxicity. 
Ultimately the most important question is whether the lead NAAQS protects human health with an 
“adequate margin of safety” as mandated under section 109 of the Clean Air Act (42 U.S.C. 7409) 
[20]. We contend that any analysis that does not include explicit consideration of susceptibility will be 
unable to provide a sufficient answer. The results of our analysis will illuminate why CRA is needed to 
inform policy development and will provide valuable lessons for evaluating cumulative risks within a 
policy decision framework. 
2. Methods 
2.1. EPA Analytical Approach  
To assess the adequacy of the original 1978 lead NAAQS of 1.5 µg/m
3, EPA undertook a lengthy 
and thorough review process, synthesizing over 6,000 scientific articles, soliciting expert and public 
comments, and performing a risk assessment (73 FR 66964) [11,21–23]. The standard itself consisted 
of four parts: an indicator, averaging time, form, and level. The 2008 revision set the lead NAAQS at a 
level of 0.15 µg/m
3 with a rolling three-month averaging time and a maximum not-to-be-exceeded 
form, evaluated over a three-year period. The final standard arose from three key considerations 
encompassed in EPA’s decision framework: (1) choice of analysis parameters; (2) identification of the 
target population; and (3) determination of an acceptable risk level. 
Analysis Parameters: The analysis required selection of: (1) CR functions; (2) air-to-blood lead 
ratios; and (3) potential standard levels. Firstly, to select CR functions EPA reviewed the scientific 
literature focusing on epidemiological studies that examined the effect of blood lead on IQ in children. 
After culling the dataset to four studies, the median CR function was chosen (−1.75 IQ points/µg/dL 
blood lead) to ward against undue influence from a single estimate (73 FR 67003) [11]. Secondly, 
based on available evidence [22,24], EPA evaluated a range of air-to-blood lead ratios developed in Int. J. Environ. Res. Public Health 2012, 9  1080 
 
 
children (1:5, 1:7, 1:10). Ratios are presented as 1:x, with 1 representing air lead (µg/m
3) and x 
representing blood lead (µg/dL). Finally, a range of potential lead standards were considered from 0.02 
to 0.5 µg/m
3. 
Target Population: The EPA framework “provides estimates for that subset of children likely to be 
exposed to the level of the standard, which is generally expected to be the subpopulation of children 
living near sources who are likely to be most highly exposed…the framework does not provide 
estimates of the mean air-related IQ loss for all U.S. children” (73 FR 67005) [11]. 
Acceptable Risk: As EPA stated, “the Administrator concludes that an air-related IQ loss of 2 points 
should be used in conjunction with the evidence-based framework in selecting an appropriate level for 
the standard” (73 FR 67005) [11]. This decision was informed by the U.S. EPA Clean Air Scientific 
Advisory Committee which cautioned against a population mean IQ loss greater than 1–2 points in all 
but a small percentile of the population [25]. 
2.1.1. Determining the Lead NAAQS 
Table 1 displays the results of EPA’s analysis of expected target population mean IQ loss based on 
different levels of the standard, CR function, and air-to-blood lead ratio. IQ loss  was calculated 
through the following equation: 
β × A × B = IQ Loss  (1)  
where β is the slope of change in IQ associated with a 1 µg/dL increase in blood lead (β = −1.75 IQ 
points/µg/dL blood lead for all calculations), A is the potential standard level considered, and B is the 
air-to-blood lead ratio.  
Table 1. Expected mean IQ loss estimates for children exposed at the level of the standard.  
Potential Level for 
Standard (µg/m
3) 
Air-to-Blood Lead Ratio* 
1:5  1:7  1:10 
0.50  4.4 (3.9–7.4)  >5 
a  >5 
a 
0.40  3.5 (3.1–5.9)  4.9 (4.4–8.2) 
b 
0.30  2.6 (2.3–4.4)  3.7 (3.3–6.2)  5.3 (4.7–8.8) 
0.25  2.2 (2.0–3.7)  3.1 (2.7–5.1)  4.4 (3.9–7.4) 
0.20  1.8 (1.6–2.9)  2.5 (2.2–4.1)  3.5 (3.1–5.9) 
0.15  1.3 (1.2–2.2)  1.8 (1.6–3.1) 
c  2.6 (2.3–4.4) 
0.10  0.9 (0.8–1.5)  1.2 (1.1–2.1)  1.8 (1.6–2.9) 
0.05  0.4 (0.4–0.7)  0.6 (0.5–1.0)  0.9 (0.8–1.5) 
0.02  0.2 (0.2–0.3)  0.2 (0.2–0.4)  0.4 (0.3–0.6) 
* Ranges are based on the lowest and highest concentration-response functions. 
a For these combinations of 
air-to-blood ratio and standard, the resulting estimate is too uncertain to state with precision; 
b Not reported;  
c Final standard level and associated mean IQ loss highlighted for emphasis; Reference: 73 FR 66964 [11]. 
As shown in Table 1, under an air-to-blood lead ratio of 1:7 a standard of 0.15 µg/m
3 would result 
in a loss of <2 IQ points in the target population mean, meeting the acceptable risk criterion. We note 
that EPA undertook a careful evaluation of other aspects of the lead standard. Choice of averaging time 
and form was also directly relevant to the selection of a final standard, though we do not focus on these Int. J. Environ. Res. Public Health 2012, 9  1081 
 
 
properties in our analysis. It is the standard level of 0.15 µg/m
3 in conjunction with a rolling three-
month averaging time and a maximum not-to-be-exceeded form that “would significantly reduce and 
limit for a high percentage of U.S. children the risk of experiencing an air-related IQ loss of (2 points)” 
(FR 73 67005) [11].  
2.2. Incorporation of Susceptibility  
While there were numerous considerations that were involved in the selection of a lead NAAQS, 
our analysis focused mainly on the choice of CR function. We conserved the standard levels EPA 
evaluated as well as child air-to-blood lead ratios. 
To identify candidate CR functions we relied on a previously conducted systematic review of 
studies assessing SES as an effect modifier of lead toxicity for neurocognitive, renal, and cardiovascular 
(hypertension) outcomes [26]. CR functions for neurocognitive outcomes were included in the present 
analysis if their associated studies focused on children, measured lead in blood, assessed global aspects 
of cognitive function (Mental Development Index (MDI) or IQ), and reported separate estimates for 
each socioeconomic level. 
2.2.1. Data Analysis 
We considered various methods for combining individual study CR functions, from simple median 
values to inverse variance weighting by susceptibility subgroup. Following EPA’s methods, we 
included a range of standard levels and air-to-blood lead ratios in our analysis. Expected outcomes 
(neurocognitive abilities in children) associated with different standard levels were determined 
according to the following equation: 
βj × A × B = yj  (2)  
where A is the potential standard level, βj is the regression coefficient relating the expected change in 
cognitive ability associated with a 1 µg/dL increase in blood lead in susceptibility subgroup j, B is the 
child-specific air-to-blood lead ratio, and yj is the resulting neurocognitive outcome in susceptibility 
subgroup j (e.g., loss of IQ or MDI points).  
3. Results  
3.1. Description of Data 
Table 2 presents descriptions of the CR functions considered for the analysis. Four neurocognitive 
studies met our inclusion criteria [16,27–29]. Three studies were prospective in design [16,28,29] and 
one was cross-sectional [27]. The three prospective studies actually represent data from two cohorts 
evaluated over time. Dietrich et al. [28] focused on a cohort of Cincinnati-based infants assessed at six 
months. (We initially identified two studies by Dietrich et al. [14,28]; both focused on infants assessed 
at six months–however the form of lead differed between studies (untransformed [14] versus natural 
log transformation [28]). We chose to include the function involving a log transformation of blood  
lead because of the large research base supporting the nonlinear relationship between lead and 
neurocognitive function [21].) Both McMichael et al. [29] and Tong et al. [16] analyzed data from 
children living in the areas surrounding a lead smelter in Port Pirie, Australia.  Int. J. Environ. Res. Public Health 2012, 9  1082 
 
Table 2. Concentration-response functions considered in the analysis. 
β (SE or 95th CI if 
reported) 
a 
Susceptibility  Lead 
Form 
Lead 
Measure 
Overall Lead 
Mean (µg/dL) 
Outcome  Age at Assessment  Reference 
        Studies used by EPA to determine concentration-response function       
                −1.71  Overall  Linear  Concurrent  2.9 (0.8–4.9) 
b,c  MDI (BSID)  24 months  Tellez-Rojo et al. [30] 
−2.94  Overall  Linear  Concurrent  3.2 (0.9–7.4) 
b,c  IQ (WISC-R)  4–10 years  Lanphear et al. [31] 
d 
−1.79  Overall  Linear  Concurrent  3.3 (0.5–8.4) 
b,c  IQ (SBIS)  5 years  Canfield et al. [32] 
−1.56  Overall  Linear  Neonatal  3.8 (1.0–9.3) 
b,c  IQ (WISC-R)  10 years  Bellinger & Needleman [33] 
                Studies with SES-subgroup specific effects included in the analysis       
                −4.70  Low SES  Ln  Neonatal  4.5 (2.9)  MDI (BSID)  6 months  Dietrich et al. [28]  
−4.90 
e 
−4.57 
e 
−1.87 
e 
Low SES 
Middle SES 
High SES 
Ln 
Average 
Postnatal 
21.3 
(13.3–33.8) 
f 
MDI (BSID)  2 years  McMichael et al. [29]  
−9.60 (3.60) 
−2.90 (3.40) 
Low SES 
High SES 
Ln 
Lifetime 
Average 
14.1 (1.2) 
b  IQ (WISC-R)  11–13 years  Tong et al. [16]  
−0.03  Manual  Linear  Concurrent  15.6 (4.1)  IQ (BAS)  2–6 years  Harvey et al. [27]  
a Estimates are interpreted as change in test score per 1 µg/dL increase in blood lead level; 
b Geometric mean; 
c Range (minimum-maximum); 
d The Lanphear et al. [31] pooled study 
included data from the cohorts analyzed by Canfield et al.  [32]  and Bellinger and Needleman  [33]  but for different ages; 
e  Unadjusted estimates; 
f  Range  
(25th to 75th percentile). Abbreviations: SES (socioeconomic status); MDI (Mental Development Index); BSID (Bayley Scales of Infant Development); IQ (intelligence quotient); 
SBIS (Stanford-Binet Intelligence Scale); WISC-R (Wechsler Intelligence Scale for Children-Revised); BAS (British Ability Scales). 
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The presence of the lead smelter may explain the higher population mean blood lead levels found in 
the Port Pirie versus Cincinnati cohort (Table 2). For comparison purposes, Table 2 also includes the 
four studies chosen by EPA to determine the CR function used in their analysis to select the lead 
standard [30–33]. 
Figure 1 displays individual CR functions grouped according to SES. To interpret the nonlinear 
models, we calculated slopes at a blood lead level of 2 µg/dL. Many of the neurocognitive studies did 
not report enough information to calculate variability estimates. Overall there do appear to be slight 
shifts in the distribution of functions based on susceptibility group. CR functions developed in low and 
high SES groups tend to fall below and above the mean respectively. 
Figure 1. Concentration-response (CR) functions for neurocognitive outcomes in children 
(intelligence quotient and mental development index) grouped according to socioeconomic 
status. CR functions are calculated at 2 µg/dL blood lead level. Error bars represent 95% 
confidence intervals. Vertical dotted line represents mean CR estimates across studies. 
 
3.2. Selection of Parameters and Analysis Results 
3.2.1. Concentration-Response Functions 
For susceptibility subgroups with multiple CR functions we determined both the median value and 
a pooled estimate using inverse variance weighting and random effects methods (Table 3).  We  
were unable to calculate pooled estimates for all groups because of lack of reported variability 
estimates in the neurocognitive studies. For nonlinear models, the CR functions in Table 3 represent 
the effect of blood lead at 2 µg/dL. We chose this level as the most recent (2007–2008) NHANES data 
indicates that the mean lead levels in the United States for various age groupings tends to fall under  Int. J. Environ. Res. Public Health 2012, 9  1084 
 
 
2 µg/dL. If studies reported low, medium, and high SES estimates, we only used high and low SES CR 
functions to simplify comparisons. 
Table 3. Individual and combined concentration-response functions at 2 µg/dL blood lead level. 
Reference  Susceptibility 
CR Function 
(95% CI) 
Median CR 
(95% CI) 
Pooled CR 
(95% CI) 
          Tellez-Rojo et al. [30]   Overall  −1.71 (−3.00, −0.42) 
−1.75 
(−3.00, −0.51) 
−1.82 
(−2.52, −1.12) 
Lanphear et al. [31]   Overall  −2.94 (−5.16, −0.71) 
Canfield et al. [32]  Overall  −1.79 (−3.00, −0.60) 
Bellinger & Needleman [33]  Overall  −1.56 (−2.90, −0.20) 
          McMichael et al. [29]   High SES  −0.94 
-1.19  NA 
Tong et al. [16]   High SES  −1.45 (−4.78, 1.88) 
          Dietrich et al. [28]   Low SES  −2.35 
−2.40  NA 
McMichael et al. [29]   Low SES  −2.45 
Tong et al. [16]   Low SES  −4.80 (−8.33, −1.27) 
Harvey et al. [27]   Low SES  −0.03 
Abbreviations: CR (concentration-response); SES (socioeconomic status); HS (high school). 
3.2.2. Ratios and Standard Levels 
Acknowledging uncertainty in the estimates, EPA’s final analysis for the revision of the NAAQS 
consisted of a range of child-specific ratios with 1:5, 1:10, and 1:7 representing the lower and upper 
bounds, and central estimate respectively. We used these ratios in our analysis. 
Based on a review of scientific evidence, expert recommendations, and public comments, EPA 
considered a range of levels for the new standard (0.02, 0.05, 0.10, 0.15, 0.20, 0.25, 0.30, 0.40, and 
0.50 µg/m
3) (73 FR 66996) [11]. EPA noted that many commentators recommended an upper level of  
0.20 µg/m
3 for the final standard. We retain the same range of levels for our analyses. 
3.3. Analysis Results 
Table 4 displays expected IQ loss associated with different levels of the air lead standard using a 
CR function developed in low SES groups (β = −2.40 points/µg/dL blood lead). Results are presented 
using median CR estimates to represent susceptibility subgroups with multiple functions available. 
(Similar results were found using pooled estimates.)  Compared to the values in Table 1, at all   
potential  standard levels we note a greater expected decrease in population mean IQ using  these  
susceptibility-specific estimates. Under the 0.15  µg/m
3  standard, the loss in IQ at the central   
air-to-blood lead ratio exceeds the 2-point acceptable risk level set by EPA (73 FR 67005) [11]. 
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Table 4.  Expected mean intelligence loss estimates for children at different air lead 
standard levels using concentration-response functions developed in low socioeconomic 
groups *. 
Potential Standard 
(µg/m
3) 
Air-to-Blood Lead Ratio 
1:5  1:7  1:10 
0.02  0.2 (0.00, 0.5)  0.3 (0.00, 0.7)  0.5 (0.01, 0.1) 
0.05  0.6 (0.01, 1.2)  0.8 (0.01, 1.7)  1.2 (0.02, 2.4) 
0.10  1.2 (0.02, 2.4)  1.7 (0.02, 3.4)  2.4 (0.03, 4.8) 
0.15  1.8 (0.02, 3.6)  2.5 (0.03, 5.0)  3.6 (0.1, 7.2) 
0.20  2.4 (0.03, 4.8)  3.4 (0.04, 6.7)  4.8 (0.1, 9.6) 
0.25  3.0 (0.04, 6.0)  4.2 (0.1, 8.4)  6.0 (0.1, 12.0) 
0.30  3.6 (0.15, 7.2)  5.0 (0.1, 10.1)  7.2 (0.1, 14.4) 
0.40  4.8 (0.16, 9.6)  6.7 (0.1, 13.4)  9.6 (0.1, 19.2) 
0.50  6.0 (0.1, 12.0)  8.4 (0.1, 16.8)  12.0 (0.2, 24.0) 
* Ranges are based on the lowest and highest concentration-response functions. 
4. Discussion  
4.1. Overview of Results 
To determine the NAAQS for lead, EPA developed an evidence-based framework for estimating IQ 
loss from exposure to lead in air. Expected decreases in function were determined through an analysis 
and combination of multiple data elements. The process was informed by an important decision 
criterion–EPA would reject any standard that resulted in greater than a 2-point IQ loss in the 
population mean of children exposed at the level of the standard. 
EPA defined children as the most sensitive population but did not consider additional 
susceptibilities that might modify the adverse effects of lead. The Agency’s original analysis used a 
CR function that resulted in an estimated mean IQ loss of 1.8 points at the 0.15 µg/m
3 standard level. 
Our analysis showed that the  use of CR functions developed in groups more susceptible to lead 
toxicity resulted in cognitive decrements that exceeded the acceptable risk level set by EPA (−2.5 IQ 
loss/µg/dL blood lead, Table 4). Retaining EPA’s decision criterion, a lower standard of 0.10 µg/m
3 
would be necessary to protect against a greater than 2-point IQ loss in the target population mean. 
The potential for children of greater socioeconomic disadvantage to display greater susceptibility to 
lead is an important concern–especially as EPA’s IQ-loss framework specifically refers to the subset 
of children who would likely be exposed at the level of the standard (73 FR 67005) [11]. While we 
lack the data to accurately quantify or characterize this group, it is possible that children more likely to 
live near lead sources (and thus be exposed at the standard level) are also more likely to suffer 
economic disadvantage [34–36]. By using CR functions that do not account for the possibility of 
increased susceptibility in this group, EPA’s IQ-loss framework may not protect the target population 
to the desired extent. 
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4.1.1. Analysis Limitations 
Our analysis was a critical exercise aimed at evaluating how susceptibility could be explicitly 
incorporated into environmental policy in order to draw lessons for risk assessment. Our final 
estimates are subject to uncertainty primarily due to inadequacies in the database. We note some key 
differences between the CR functions used in our approach versus  EPA’s analysis that affect the 
comparability of our estimates. 
Given the evidence of nonlinearity between blood lead level and IQ loss (where a steeper slope 
occurs at lower lead concentrations), EPA selected CR functions developed in study populations with 
blood lead levels closest to the low levels currently experienced by children. Because of this nonlinear 
relationship, CR functions derived from populations with higher mean lead levels would actually 
underestimate the adverse effects of lead in children today. Unfortunately the neurocognitive studies 
we identified were all conducted in cohorts with mean lead levels much greater than current levels  
(~4 to 15 versus 2 µg/dL). 
In addition,  EPA’s analysis focused on concurrent measures of blood lead and neurocognitive 
function because of evidence supporting a strong association between the two parameters. However, of 
the studies we identified that explored socioeconomic differences in lead effects, only one used 
concurrent measures of blood lead; the rest used lifetime average or neonatal blood lead measures. 
Finally, we note that at the present time, the epidemiological literature provides only suggestive 
evidence of SES as an effect modifier of lead neurotoxicity [26]. In Chari et al. [26], we identified 
forty studies that explored differential lead effects across SES groups; however only a small subset of 
these studies provided enough information to determine socioeconomic subgroup estimates. The four 
studies used in our analysis do not by themselves provide definitive evidence about the existence or 
magnitude of socioeconomic interactions with lead. It is also important to consider that different SES 
measures were used across the studies, potentially hindering comparability. Additionally, in the 
Cincinnati cohort, the authors found significant interactions between SES and lead in earlier but not 
later years indicating that effects may not persist or may be attenuated by undetermined circumstances. 
The effect of socioeconomic position on lead neurotoxicity is a complex phenomenon and our analysis 
presents a simplified assessment in order to draw larger policy implications. 
4.2. Role for Cumulative Risk Assessment in Policy Development 
As part of their methodology, EPA performed a traditional risk  assessment to support the 
development of the lead NAAQS; however uncertainties and limitations prevented the Agency from 
relying on the final estimates. EPA noted that the multimedia and persistent nature of lead along with 
the potential for multiple exposure pathways made the risk assessment considerably more complex 
than assessments for other criteria pollutants that focused on inhalation exposures only (73 FR 66979) 
[11]. Regardless, risk assessment results were used to provide additional perspectives on expected IQ 
loss resulting from air-lead exposure. Four CR functions were derived from an international pooled 
analysis  [31]  to account for uncertainty in the exposure-outcome relationship at low blood lead 
concentrations  [22]. Differential susceptibility was not considered in the risk assessment (beyond 
focusing on children as the sensitive population). Int. J. Environ. Res. Public Health 2012, 9  1087 
 
 
Though central to CRA, we should note that issues of susceptibility have been considered in 
traditional risk assessments. For noncancer endpoints, EPA estimates acceptable exposure levels or 
reference doses (RfDs)–the amount of daily exposure to chemical toxins unlikely to result in harm 
over a lifetime [37]. In the estimation of the RfD, 10-fold uncertainty factors are typically applied to 
account for interspecies extrapolation, human variation in sensitivity, lack of chronic data, as well  
as other data deficiencies.  The use of a single 10-fold uncertainty factor  for human variation in 
susceptibility has been questioned  however, especially in light of more recent efforts to address 
cumulative exposures to multiple chemicals, inter-individual variability in health risk factors, and the 
clustering of multiple vulnerability factors within individuals or populations [1–3]. For cancer endpoints, 
slope factors represent the upper bound on the average population risk and EPA considers the use of 
upper bounds to be protective for susceptible populations [2]. However, risks can be underestimated if 
the slope factors are derived from studies on populations that have less susceptibility that average (e.g., 
healthy workers) or do not include exposures during susceptible life stages in the design. 
Overall, risk assessment guidelines recommend incorporating information about susceptibility into 
all steps of the process [38–41]. EPA acknowledges however, that in practice we usually lack 
information about the range of susceptibility in a population. Furthermore, in its guidelines, the 
Agency tends to emphasize intrinsic susceptibility characteristics (fixed, inherent aspects of an 
individual) such as genetic polymorphisms or metabolism rates, and excludes consideration of 
acquired characteristics (variable, modifiable traits) such as psychological stress or SES [7]. With its 
emphasis on combined risks, CRA is well suited to address the broader acquired characteristics. 
Schwartz et al. [42] note that the focus on intrinsic susceptibility characteristics may arise from the 
fact that presently, these data are easier to collect and analyze. However upstream susceptibility 
factors, such as SES may in fact be the more important drivers of environmental health disparities. 
While both intrinsic and acquired susceptibility factors are important, the latter are especially valuable 
for public health purposes as these factors are amenable to intervention. 
4.2.1. Susceptibility and Decision-making 
The legislative history of the Clean Air Act, Section 9, includes a discussion of those who primary 
ambient air quality standards should protect: 
“…included among those persons whose health should be protected by the ambient standard are 
particularly sensitive citizens…who in the normal course of daily activity are exposed to the 
ambient environment…an ambient air quality standard, therefore, should  be the maximum 
permissible ambient air level of an air pollution agent…which will protect the health of any 
group in the population.” (S. Rep. No. 91-1196, 91st Cong., 2d Sess. 10 (1970)) [43]. 
Based on the language of the Senate Committee Report accompanying the Clean Air Act, air 
standards should be considered “adequate” if they are stringent enough to protect especially sensitive 
groups. Consideration of susceptibility thus appears to be a legislative requirement for the development 
of the NAAQS. 
However, even after the selection of a sensitive population such as children, dealing with variability 
in response to exposure remains a difficult task, made even more so when data are inadequate to Int. J. Environ. Res. Public Health 2012, 9  1088 
 
 
characterize the extent of variability. In the absence of data,  research indicates that individuals   
are “quite bad at making complex, unaided decisions”  [44].  Without explicit and quantitative 
consideration of susceptibility, policy decisions may be less protective and less equitable  [45]. 
Quantifying susceptibility will allow for more informed choices, better assessment of decision 
consequences, and increased accountability and transparency in policy development. A number of 
specific policy issues arose from our analysis that illustrate why better quantification of acquired 
susceptibility factors is needed to improve decision-making. 
4.2.2. Defining Acceptable Risks 
The determination of an acceptable risk level is a value-laden policy judgment and represents one 
type of decision uncertainty [46,47]. This type of uncertainty arises when there is ambiguity regarding 
how to value social objectives. EPA was careful in describing its choice of a <2 point IQ loss to guide 
policy decisions stating that,  
“EPA is not determining a specific quantitative public health policy goal in terms of an   
air-related IQ loss that is acceptable or unacceptable in the U.S. population per se, but instead  
is determining what magnitude of estimated air-related IQ loss should be used in conjunction 
with the specific…evidence-based framework being applied in this review, recognizing the 
uncertainties and limitations in this framework…the estimated air-related IQ loss resulting from 
the application of this evidence-based framework should not be viewed as a bright line estimate 
of expected IQ loss in the population that would or would not occur. Nonetheless, these results 
provide a useful guide…to use in making the basically qualitative public health policy judgment 
about the risk to public health that could reasonably be expected to result from exposure….”  
(FR 73 67000) [11]. 
EPA’s decision to use a loss of 2 IQ points as a criterion was not made prior to carrying out the 
analysis. Instead the Agency concluded that this acceptable risk level was a fair judgment given the 
various decision elements, expert and public comments, and uncertainty in the estimates. However as 
noted by Hattis and Anderson [45], quantitative assessment of variability can lead to “richer and more 
accurate information available for decision-making.” Even if data are not sufficient to base a decision 
on, the process of gathering and assessing available information may help inform policy-decision 
frameworks. As an example, Figure 2 graphically illustrates the range of IQ loss estimates expected at 
each potential level of the standard comparing the results of EPA’s original analysis with estimates 
generated from CR functions developed in low- and high-socioeconomic groups. Figure 2a is a simple 
graphical depiction of data shown in Table 1 for IQ loss estimates associated with the central   
air-to-blood lead ratio. Figure 2b depicts “high-end” estimates generated from the largest CR functions 
available in each population group (see Table 3). In both figures, results using EPA’s   
analysis parameters are depicted with triangle symbols and fall in the middle of IQ loss estimates 
generated from our analysis using susceptibility specific data.  At standard levels above   
0.15 µg/m
3 only estimates derived from high-SES groups (circle symbol) fall under or close to the 
acceptable risk level. At standards below a level of 0.10 µg/m
3 loss estimates from all groups meet 
acceptability requirements.  Int. J. Environ. Res. Public Health 2012, 9  1089 
 
Figure 2. Comparison of IQ loss estimates derived from general population and susceptible groups for two scenarios: (A) central estimates 
derived from median concentration-response (CR) functions; and (B) high-end estimates generated from the largest available CR function in 
each population (see Table 3). Differences across population groups are grouped according to potential standard level. Dotted line at 2 IQ 
points represents the acceptable risk level defined by EPA. A box surrounds estimates associated with the final standard. 
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EPA’s analysis  suggested that a level of 0.15 µg/m
3  would fulfill decision criteria, but by 
incorporating susceptibility we see that standard considerations could  reasonably be extended to   
0.10 µg/m
3. EPA considered its final judgments adequate due to a tendency to make conservative 
decisions across multiple decision elements. Even if an explicit accounting of susceptibility does not 
change final decisions, the analysis itself is important for increasing the transparency of a decision 
process filled with uncertain inputs.  
As Rodricks [47] notes, despite their importance, acceptable risk issues have received little public 
health evaluation. Lead is an especially difficult pollutant to assess because of its ubiquity and the lack 
of a threshold under which no adverse effects occur. Because of this reality, policymakers must make 
controversial choices regarding what level of risk, or loss of function is acceptable and to whom. 
Furthermore, unlike with carcinogens, these decisions must be made without any historical guidance. 
The NRC has recommended that EPA unify cancer and noncancer dose-response assessments which 
may result in a greater number of “noncancer” chemicals evaluated under a no-threshold model [6]. 
EPA has already noted the lack of accepted criteria within the public health community for the 
appropriate degree of protection afforded to neurocognitive effects in susceptible populations   
(FR 73 66997) [11]; if NRC recommendations come to pass, in the future we can expect to see less 
regulatory “bright lines” indicating safe exposure levels and more deliberation over acceptable risks. 
Susceptibility should be central to these conversations. Risk decisions are already difficult, 
controversial, and subject to criticism from stakeholders [7]. The determination and acceptability of an 
“acceptable” risk depends on the population to which it is applied. To be effective, relevant, and 
scientifically justifiable, environmental policies must account for susceptible populations. 
4.2.3. Prioritizing Decision Elements 
Quantitative information on susceptibility can benefit decision-making by directly addressing issues 
of inequity and helping to target interventions [47]. Both of these issues require adequate identification 
of susceptible groups and characterization of expected effects within each group. Any “one-size-fits-all” 
standard will result in variable effects because of variability in both exposure and susceptibility across 
a population. The result will be continued disparities in adverse outcomes due to environmental 
exposure. Data on susceptibility would help to identify exactly which groups may not be sufficiently 
protected by the current lead NAAQS for example. Additional “downstream” interventions could then 
be targeted towards those populations.  
During policy development information about susceptibility can be used to inform the process by 
allowing comparisons across vulnerable subpopulations. The base of research currently best 
substantiates child neurological and adult cardiovascular functioning as most sensitive to lead at low 
blood levels. Lead bioaccumulates in the body, with bone serving as the largest storage component. 
Throughout life, lead is exchanged between blood and bone as well as blood and soft tissues [21]. 
Based on the fact that blood lead levels in adulthood are influenced by previous exposures, EPA gave 
precedence to children as the susceptible subpopulation and reasoned that the lead NAAQS should 
offer adequate protection against cardiovascular and renal effect in adults (73 FR 66975) [11]. While 
children and neurotoxicity are important targets for public health intervention, it is possible that other 
susceptibility groups and health outcomes warrant explicit consideration within a decision framework. Int. J. Environ. Res. Public Health 2012, 9  1091 
 
 
4.3. Data Needs for Cumulative Risk Assessment 
As mentioned previously, CRA is an ideal framework for integrating acquired susceptibility factors 
into research and policy. Unlike intrinsic factors which can be represented by animal models, acquired 
characteristics are best explored through epidemiological studies. Levy [5] noted that though epidemiology 
captures many issues germane to CRA, there is presently little guidance available for its use in 
assessing cumulative risks. The NRC [6] however has highlighted the utility of social epidemiology to 
inform CRA while Levy [5] provides a conceptual framework for incorporating epidemiology into the 
process.  In a recent paper, Schwartz et al.  [48]  discuss three challenges to studying differential 
vulnerability and susceptibility using epidemiological data and potential methods to address them. 
These challenges include disentangling complex interactions and synergies, incorporating spatially and 
temporally nested data, and quantifying risk inequalities to determine pockets of vulnerabilities. 
To incorporate susceptibility into CRA, more and better data is needed to identify, characterize, and 
prioritize potential factors. Our analysis used SES as a potential effect modifier of lead toxicity 
because of its wide use in the epidemiological literature and its omnibus nature. SES serves as a proxy 
for numerous other potential lead-related susceptibility factors such as poor iron or calcium intake [49–52], 
high stress [53–58], cumulative exposures [59–62], or the presence of comorbidities [63]. From a 
policy perspective, SES as a variable is valuable for its potential to capture the adverse effects of 
multiple susceptibilities. The NRC recommends a focus on SES for this very reason [6]. We note 
though that concentrating on SES is less helpful for delineating specific pathways of effect and 
determining which are most important for modifying lead toxicity. Measuring susceptibility through 
SES may be better suited to environmental regulatory decisions such as setting a NAAQS; however 
public health programs and interventions implemented at a smaller scale would benefit from more 
focused and specific susceptibility measures. 
Finally we note that even when data on susceptibility is too uncertain to realistically be used to set 
policy, examining the information quantitatively can still be a valuable endeavor. For example, 
although EPA performed a risk assessment to support the development of the lead NAAQS, uncertainties 
regarding the design of the assessment, estimation of lead concentrations in environmental media and 
blood, and calculations of lead-related IQ loss led the Agency to focus on an evidence-based approach 
rather than the derived risk estimates in making their final decisions. However, risk assessment results 
were still evaluated to provide additional perspective. As long as limits are known, imperfect data can 
still be considered in a decision context even if its value is questioned from a scientific point-of-view. 
The act of gathering and assembling data may itself be beneficial as the process can help to direct 
research efforts towards the types of data that will be most useful to policymakers for future   
decision-making. 
5. Conclusions  
In contrast to traditional risk assessment, CRA asks broader questions, is situated within a larger 
public health context, and addresses multiple health determinants simultaneously. As the methodology 
improves, CRA may become an increasingly valuable tool for policymakers, public health 
practitioners, and the public at-large. However CRA’s complexity is currently its greatest liability; the Int. J. Environ. Res. Public Health 2012, 9  1092 
 
 
approach requires a strong research foundation across multiple disciplines. Without adequate data, 
incorporation of susceptibility into environmental policy remains a challenge.  
In conclusion, we found that the use of data developed in susceptible populations would result in 
the selection of a more protective lead NAAQS under the same decision framework applied by EPA. 
Our study raises important questions about the adequacy of current environmental standards for 
protecting all populations and underscores the need to develop guidance for incorporating 
susceptibility into public health research and policy.  
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